Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma

被引：0
|
作者：
Meena N. Murugappan
Bellinda L. King-Kallimanis
Vishal Bhatnagar
Bindu Kanapuru
Joel F. Farley
Randall D. Seifert
David D. Stenehjem
Ting-Yu Chen
Erica G. Horodniceanu
Paul G. Kluetz
机构：
[1] U.S. Food and Drug Administration (U.S. FDA),Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER)
[2] LUNGevity Foundation,Center for Drug Evaluation and Research (CDER)
[3] Oncology Center for Excellence (U.S. FDA),Department of Pharmaceutical Care and Health Systems
[4] U.S. Food and Drug Administration (U.S. FDA),Department of Pharmacy Practice and Pharmaceutical Sciences
[5] University of Minnesota – College of Pharmacy,undefined
[6] University of Minnesota – College of Pharmacy,undefined
[7] Oncology Center of Excellence,undefined
[8] Food and Drug Administration,undefined
来源：
Quality of Life Research | 2023年 / 32卷
关键词：
Patient-reported outcomes; Frailty; Multiple myeloma; Geriatric oncology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2281 / 2292
页数：11
相关论文
共 50 条
  • [31] Measuring Patient Reported Outcomes in Multiple Myeloma: Are Legacy Instruments Fit for Purpose
    Gries, Katharine S.
    Fastenau, John
    Iaconangelo, Charlie
    Serrano, Daniel
    BLOOD, 2018, 132
  • [32] ASSOCIATION BETWEEN ADHERENCE TO LENALIDOMIDE AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE SEARCH
    Ramasamy, K.
    von Lilienfeld-Toal, M.
    Maisel, C.
    Gustavsson, B.
    Back, K.
    Glasmacher, A.
    Leleu, X.
    VALUE IN HEALTH, 2023, 26 (12) : S6 - S7
  • [33] Assessing the Effect of Adherence on Patient-reported Outcomes and Out of Pocket Costs Among Patients With Multiple Myeloma
    Gupta, Shaloo
    Abouzaid, Safiya
    Liebert, Ryan
    Parikh, Kejal
    Ung, Brian
    Rosenberg, Aaron S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (03): : 210 - 218
  • [34] A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma
    Mian, Hira
    Seow, Hsien
    Balitsky, Amaris K.
    Cheung, Matthew C.
    Gayowsky, Anastasia
    Tay, Jason
    Wildes, Tanya M.
    McCurdy, Arleigh
    Visram, Alissa
    Sandhu, Irwindeep
    Sutradhar, Rinku
    ONCOLOGIST, 2024, 29 (06): : 519 - 526
  • [35] Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency in Patients with Multiple Sclerosis: Patient-Reported Outcomes (PRO)
    Baharnoori, Moogeh
    Wong, Stephen
    Hohol, Marika
    O'Connor, Paul
    NEUROLOGY, 2013, 80
  • [36] Technological developments enable measuring and using patient-reported outcomes data in orthopaedic clinical practice
    Hamilton, David F.
    Giesinger, Johannes M.
    Giesinger, Karlmeinrad
    WORLD JOURNAL OF ORTHOPEDICS, 2020, 11 (12): : 584 - 594
  • [37] FEASIBILITY AND ACCEPTABILITY OF MEASURING CERVIX CANCER SPECIFIC PATIENT-REPORTED OUTCOMES IN CLINICAL PRACTICE
    Atallah, Soha
    Barbera, Lisa
    Folwell, Matthew
    Howell, Doris
    Croke, Jennifer
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S100 - S100
  • [38] Assessing and demonstrating data saturation in qualitative patient-reported outcomes (PRO) research
    Kerr, Cicely
    Nixon, Annabel
    Wild, Diane
    QUALITY OF LIFE RESEARCH, 2010, 19 : 124 - 124
  • [39] Patient-reported outcomes helped predict survival in multiple myeloma using partial least squares analysis
    Viala, Muriel
    Bhakar, Asha L.
    de la Loge, Christine
    de Velde, Helgi van
    Esseltine, Dixie
    Chang, Mark
    Dhawan, Ravinder
    Dubois, Dominique
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2007, 60 (07) : 670 - 679
  • [40] ASSESSING PATIENT-REPORTED OUTCOMES AND WORK PRODUCTIVITY ALONG THE MULTIPLE MYELOMA (MM) PATIENT JOURNEY
    Gupta, S.
    Clancy, Z.
    Doane, M. J.
    VALUE IN HEALTH, 2018, 21 : S18 - S18
12345